NYSE:GMED Globus Medical (GMED) Stock Price, News & Analysis $71.89 +0.14 (+0.20%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$71.65▼$73.0950-Day Range$65.09▼$73.4052-Week Range$43.38▼$74.16Volume785,711 shsAverage Volume1.08 million shsMarket Capitalization$9.73 billionP/E Ratio112.33Dividend YieldN/APrice Target$73.30 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get Globus Medical alerts: Email Address Globus Medical MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.64 Rating ScoreUpside/Downside2.0% Upside$73.30 Price TargetShort InterestHealthy5.02% of Shares Sold ShortDividend StrengthN/ASustainability-0.93Upright™ Environmental ScoreNews Sentiment0.96Based on 10 Articles This WeekInsider TradingSelling Shares$5.46 M Sold Last QuarterProj. Earnings Growth17.73%From $2.82 to $3.32 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.74 out of 5 starsMedical Sector58th out of 936 stocksSurgical & Medical Instruments Industry11th out of 101 stocks 2.3 Analyst's Opinion Consensus RatingGlobus Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.64, and is based on 7 buy ratings, 4 hold ratings, and no sell ratings.Amount of Analyst CoverageGlobus Medical has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Globus Medical's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted5.02% of the outstanding shares of Globus Medical have been sold short.Short Interest Ratio / Days to CoverGlobus Medical has a short interest ratio ("days to cover") of 6.7.Change versus previous monthShort interest in Globus Medical has recently decreased by 5.03%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldGlobus Medical does not currently pay a dividend.Dividend GrowthGlobus Medical does not have a long track record of dividend growth. Previous Next 4.1 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreGlobus Medical has received a 57.33% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Neurostimulators", "Synthetic bone grafts", "Artificial joints", and "Robotic surgery systems" products. See details.Environmental SustainabilityThe Environmental Impact score for Globus Medical is -0.93. Previous Next 3.9 News and Social Media Coverage News SentimentGlobus Medical has a news sentiment score of 0.96. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 10 news articles for Globus Medical this week, compared to 5 articles on an average week.Search Interest12 people have searched for GMED on MarketBeat in the last 30 days. This is an increase of 1,100% compared to the previous 30 days.MarketBeat Follows11 people have added Globus Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 1,000% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Globus Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $5,459,813.00 in company stock.Percentage Held by Insiders18.54% of the stock of Globus Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions95.16% of the stock of Globus Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Globus Medical's insider trading history. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Globus Medical are expected to grow by 17.73% in the coming year, from $2.82 to $3.32 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Globus Medical is 112.33, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 142.35.Price to Earnings Ratio vs. SectorThe P/E ratio of Globus Medical is 112.33, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 156.32.Price to Earnings Growth RatioGlobus Medical has a PEG Ratio of 2.02. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioGlobus Medical has a P/B Ratio of 2.45. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Globus Medical's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad American Hartford Gold GroupDave Ramsey Makes Big Mistake Live On AirDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.GET THE FREE GUIDE About Globus Medical Stock (NYSE:GMED)Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.Read More GMED Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GMED Stock News HeadlinesJuly 16, 2024 | insidertrades.comLeslie V. Norwalk Sells 1,000 Shares of Globus Medical, Inc. (NYSE:GMED) StockJuly 25 at 7:02 AM | americanbankingnews.comGlobus Medical (NYSE:GMED) Reaches New 52-Week High at $74.05July 26, 2024 | American Hartford Gold Group (Ad)Dave Ramsey Makes Big Mistake Live On AirDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.July 24 at 12:49 PM | markets.businessinsider.comQuest Diagnostics' Haystack Oncology Forges New MRD DealJuly 21, 2024 | americanbankingnews.comGlobus Medical, Inc. (NYSE:GMED) Receives Consensus Rating of "Moderate Buy" from AnalystsJuly 20, 2024 | finanznachrichten.deGlobus Medical Receives FDA 510(k) Clearance for ExcelsiusFlex and ACTIFY 3D Total Knee SystemJuly 20, 2024 | markets.businessinsider.comBuy Recommendation for Globus Medical Amidst Strategic Orthopedic Advances and Market ExpansionJuly 18, 2024 | americanbankingnews.comGlobus Medical (NYSE:GMED) Reaches New 1-Year High on Analyst UpgradeJuly 26, 2024 | American Hartford Gold Group (Ad)Dave Ramsey Makes Big Mistake Live On AirDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.July 17, 2024 | globenewswire.comGlobus Medical Receives FDA 510(k) Clearance for ExcelsiusFlex™ and ACTIFY™ 3D Total Knee SystemJuly 17, 2024 | americanbankingnews.comGlobus Medical, Inc. (NYSE:GMED) Director Sells $70,000.00 in StockJuly 16, 2024 | globenewswire.comGlobus Medical Schedules Second Quarter Earnings Release and Conference CallJuly 16, 2024 | globenewswire.comGlobus Medical Schedules Second Quarter Earnings Release and Conference CallJuly 16, 2024 | americanbankingnews.comGlobus Medical (NYSE:GMED) Price Target Increased to $78.00 by Analysts at Truist FinancialJuly 16, 2024 | americanbankingnews.comGlobus Medical (NYSE:GMED) Price Target Increased to $71.00 by Analysts at Morgan StanleyJune 15, 2024 | seekingalpha.comGlobus Medical: NuVasive Merger Unlocks Incremental NOPAT GrowthMay 29, 2024 | markets.businessinsider.comDeep Dive Into Globus Medical Stock: Analyst Perspectives (7 Ratings)May 29, 2024 | msn.comCrowdStrike To Rally Over 15%? Here Are 10 Top Analyst Forecasts For WednesdaySee More Headlines Receive GMED Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Globus Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/07/2024Today7/26/2024Next Earnings (Confirmed)8/06/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & medical instruments Sub-IndustryHealth Care Equipment Current SymbolNYSE:GMED CUSIP37957720 CIK1237831 Webwww.globusmedical.com Phone(610) 930-1800Fax610-930-2042Employees5,000Year FoundedN/APrice Target and Rating Average Stock Price Target$73.30 High Stock Price Target$85.00 Low Stock Price Target$58.00 Potential Upside/Downside+2.0%Consensus RatingModerate Buy Rating Score (0-4)2.64 Research Coverage11 Analysts Profitability EPS (Most Recent Fiscal Year)$0.64 Trailing P/E Ratio112.33 Forward P/E Ratio25.49 P/E Growth2.02Net Income$122.87 million Net Margins3.51% Pretax Margin4.93% Return on Equity8.82% Return on Assets7.06% Debt Debt-to-Equity RatioN/A Current Ratio2.33 Quick Ratio1.29 Sales & Book Value Annual Sales$1.57 billion Price / Sales6.20 Cash Flow$3.57 per share Price / Cash Flow20.14 Book Value$29.32 per share Price / Book2.45Miscellaneous Outstanding Shares135,370,000Free Float110,274,000Market Cap$9.73 billion OptionableOptionable Beta1.15 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for August 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. David C. Paul (Age 57)Co-Founder & Executive Chairman Comp: $1.21MMr. Daniel T. Scavilla (Age 59)President, CEO & Director Comp: $1.67MMr. Keith W. Pfeil (Age 45)CFO & COO Comp: $884.04kMs. Kelly G. Huller Esq. (Age 52)Senior VP, General Counsel & Secretary Comp: $729.34kMr. Brian J. Kearns (Age 57)Senior Vice President of Business Development & Investor Relations Key CompetitorsIDEXX LaboratoriesNASDAQ:IDXXResMedNYSE:RMDSTERISNYSE:STEHologicNASDAQ:HOLXBaxter InternationalNYSE:BAXView All CompetitorsInsiders & InstitutionsBank of New York Mellon CorpSold 403,078 shares on 7/26/2024Ownership: 1.931%Allspring Global Investments Holdings LLCSold 290,131 shares on 7/26/2024Ownership: 0.379%State of Michigan Retirement SystemSold 1,200 shares on 7/26/2024Ownership: 0.020%Mitsubishi UFJ Asset Management UK Ltd.Sold 4,000 shares on 7/26/2024Ownership: 0.010%Verdence Capital Advisors LLCSold 2,003 shares on 7/26/2024Ownership: 0.006%View All Insider TransactionsView All Institutional Transactions GMED Stock Analysis - Frequently Asked Questions How have GMED shares performed this year? Globus Medical's stock was trading at $53.29 at the beginning of the year. Since then, GMED shares have increased by 34.9% and is now trading at $71.89. View the best growth stocks for 2024 here. How were Globus Medical's earnings last quarter? Globus Medical, Inc. (NYSE:GMED) announced its quarterly earnings data on Tuesday, May, 7th. The medical device company reported $0.72 EPS for the quarter, topping analysts' consensus estimates of $0.55 by $0.17. The company's revenue was up 119.3% on a year-over-year basis. What is David Demski's approval rating as Globus Medical's CEO? 47 employees have rated Globus Medical Chief Executive Officer David Demski on Glassdoor.com. David Demski has an approval rating of 61% among the company's employees. This puts David Demski in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. Who are Globus Medical's major shareholders? Globus Medical's top institutional shareholders include Bank of New York Mellon Corp (1.93%), Vaughan Nelson Investment Management L.P. (0.84%), Boston Trust Walden Corp (0.55%) and Allspring Global Investments Holdings LLC (0.38%). Insiders that own company stock include David D Davidar, Leslie V Norwalk, Keith W Pfeil, James R Tobin, Dan Lemaitre and Kelly Huller. View institutional ownership trends. How do I buy shares of Globus Medical? Shares of GMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Globus Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Globus Medical investors own include NVIDIA (NVDA), Shopify (SHOP), CrowdStrike (CRWD), Okta (OKTA), Trade Desk (TTD), Block (SQ) and Tesla (TSLA). This page (NYSE:GMED) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Globus Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Globus Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
